United-Guardian (UG) Stock Price
United-Guardian Price
Revenue at United-Guardian has contracted by 0.8% per year over the past 19 years to 10.55 M USD. Earnings per share have declined at 1.0% per year over the last 19 years. United-Guardian's net margin stands at 20.0%, down from 33.4% several years earlier. United-Guardian currently offers a dividend yield of about 8.29%. The payout ratio is around 131% of earnings. The dividend has grown at 1.3% per year over the past 19 years. The stock trades about 29% above its 52-week low.
United-Guardian stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of United-Guardian over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how United-Guardian stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing United-Guardian's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | United-Guardian Price |
|---|---|
| 8/6/2026 | 7.24 USD |
| 8/5/2026 | 7.29 USD |
| 8/4/2026 | 7.36 USD |
| 8/3/2026 | 7.12 USD |
| 7/31/2026 | 7.05 USD |
| 7/30/2026 | 7.22 USD |
| 7/29/2026 | 7.36 USD |
| 7/27/2026 | 8.19 USD |
| 7/23/2026 | 7.76 USD |
| 7/22/2026 | 7.95 USD |
| 7/21/2026 | 7.90 USD |
| 7/20/2026 | 7.70 USD |
| 7/17/2026 | 7.55 USD |
| 7/16/2026 | 7.50 USD |
| 7/15/2026 | 7.25 USD |
| 7/14/2026 | 7.20 USD |
| 7/13/2026 | 7.33 USD |
| 7/10/2026 | 7.17 USD |
| 7/9/2026 | 7.23 USD |
| 7/8/2026 | 7.26 USD |
| 7/7/2026 | 7.31 USD |
| 7/6/2026 | 7.26 USD |
| 7/2/2026 | 7.26 USD |
| 7/1/2026 | 7.06 USD |
| 6/30/2026 | 7.14 USD |
| 6/29/2026 | 7.14 USD |
| 6/26/2026 | 7.16 USD |
| 6/25/2026 | 7.13 USD |
| 6/24/2026 | 7.19 USD |
| 6/23/2026 | 7.20 USD |
| 6/22/2026 | 6.95 USD |
| 6/18/2026 | 7.04 USD |
| 6/17/2026 | 7.02 USD |
| 6/16/2026 | 7.00 USD |
| 6/15/2026 | 7.02 USD |
| 6/12/2026 | 7.01 USD |
| 6/11/2026 | 7.02 USD |
| 6/10/2026 | 6.90 USD |
| 6/9/2026 | 6.96 USD |
| 6/8/2026 | 6.89 USD |
| 6/5/2026 | 7.01 USD |
| 6/4/2026 | 7.00 USD |
| 6/3/2026 | 6.99 USD |
| 6/2/2026 | 6.99 USD |
| 6/1/2026 | 6.99 USD |
| 5/29/2026 | 6.93 USD |
| 5/28/2026 | 7.02 USD |
| 5/27/2026 | 7.02 USD |
| 5/26/2026 | 7.10 USD |
| 5/22/2026 | 7.17 USD |
| 5/21/2026 | 7.09 USD |
| 5/20/2026 | 7.04 USD |
| 5/19/2026 | 7.10 USD |
| 5/18/2026 | 7.01 USD |
| 5/15/2026 | 7.16 USD |
| 5/14/2026 | 7.17 USD |
| 5/13/2026 | 6.99 USD |
| 5/12/2026 | 6.98 USD |
| 5/11/2026 | 7.00 USD |
| 5/8/2026 | 6.87 USD |
| 5/7/2026 | 7.00 USD |
| 5/6/2026 | 6.71 USD |
| 5/5/2026 | 7.05 USD |
| 5/4/2026 | 7.43 USD |
| 4/22/2026 | 6.75 USD |
| 4/21/2026 | 6.66 USD |
| 4/20/2026 | 6.65 USD |
| 4/17/2026 | 6.89 USD |
| 4/16/2026 | 6.65 USD |
| 4/15/2026 | 6.74 USD |
| 4/14/2026 | 6.54 USD |
| 4/13/2026 | 6.59 USD |
| 4/10/2026 | 6.55 USD |
| 4/9/2026 | 6.61 USD |
| 4/8/2026 | 6.61 USD |
| 4/7/2026 | 6.68 USD |
| 4/6/2026 | 6.63 USD |
| 4/2/2026 | 6.51 USD |
| 4/1/2026 | 6.70 USD |
| 3/31/2026 | 6.70 USD |
| 3/30/2026 | 6.64 USD |
| 3/27/2026 | 6.56 USD |
| 3/26/2026 | 6.25 USD |
| 3/25/2026 | 6.21 USD |
| 3/24/2026 | 6.22 USD |
| 3/23/2026 | 6.27 USD |
| 3/20/2026 | 6.26 USD |
| 3/19/2026 | 6.30 USD |
| 3/18/2026 | 6.43 USD |
| 3/17/2026 | 6.43 USD |
| 3/16/2026 | 6.48 USD |
| 3/15/2026 | 6.54 USD |
| 3/13/2026 | 6.68 USD |
| 3/12/2026 | 6.68 USD |
| 3/11/2026 | 6.55 USD |
| 3/10/2026 | 6.61 USD |
| 3/9/2026 | 6.57 USD |
| 3/8/2026 | 6.41 USD |
| 3/6/2026 | 6.31 USD |
| 3/5/2026 | 6.31 USD |
| 3/4/2026 | 6.50 USD |
| 3/3/2026 | 6.50 USD |
| 3/2/2026 | 6.59 USD |
| 3/1/2026 | 6.49 USD |
| 2/27/2026 | 6.72 USD |
| 2/26/2026 | 6.72 USD |
| 2/25/2026 | 6.60 USD |
| 2/24/2026 | 6.72 USD |
| 2/23/2026 | 6.54 USD |
| 2/22/2026 | 6.54 USD |
| 2/20/2026 | 6.60 USD |
| 2/19/2026 | 6.60 USD |
| 2/18/2026 | 6.57 USD |
| 2/17/2026 | 6.53 USD |
| 2/16/2026 | 6.51 USD |
| 2/13/2026 | 6.60 USD |
| 2/12/2026 | 6.60 USD |
| 2/11/2026 | 6.59 USD |
| 2/10/2026 | 6.62 USD |
| 2/9/2026 | 6.69 USD |
| 2/8/2026 | 7.01 USD |
| 2/6/2026 | 7.15 USD |
| 2/5/2026 | 7.15 USD |
| 2/4/2026 | 7.15 USD |
| 2/3/2026 | 7.28 USD |
| 2/2/2026 | 7.31 USD |
| 2/1/2026 | 7.68 USD |
| 1/30/2026 | 7.21 USD |
| 1/29/2026 | 7.21 USD |
| 1/28/2026 | 7.24 USD |
| 1/27/2026 | 6.64 USD |
| 1/26/2026 | 6.63 USD |
| 1/25/2026 | 6.47 USD |
| 1/23/2026 | 6.50 USD |
| 1/22/2026 | 6.50 USD |
| 1/21/2026 | 6.57 USD |
| 1/20/2026 | 6.53 USD |
| 1/19/2026 | 6.42 USD |
| 1/16/2026 | 6.74 USD |
| 1/15/2026 | 6.74 USD |
| 1/14/2026 | 6.39 USD |
| 1/13/2026 | 6.34 USD |
| 1/12/2026 | 6.26 USD |
| 1/11/2026 | 6.22 USD |
| 1/9/2026 | 6.25 USD |
| 1/8/2026 | 6.25 USD |
| 1/7/2026 | 6.23 USD |
| 1/6/2026 | 6.25 USD |
| 1/5/2026 | 6.20 USD |
| 1/4/2026 | 6.19 USD |
| 1/2/2026 | 6.13 USD |
| 1/1/2026 | 6.13 USD |
| 12/31/2025 | 6.16 USD |
| 12/30/2025 | 6.16 USD |
| 12/29/2025 | 6.15 USD |
| 12/28/2025 | 6.10 USD |
| 12/26/2025 | 6.20 USD |
| 12/25/2025 | 6.20 USD |
| 12/24/2025 | 6.12 USD |
| 12/23/2025 | 6.12 USD |
| 12/22/2025 | 6.12 USD |
| 12/21/2025 | 6.12 USD |
| 12/19/2025 | 6.09 USD |
| 12/18/2025 | 6.09 USD |
| 12/17/2025 | 6.06 USD |
| 12/16/2025 | 6.04 USD |
| 12/15/2025 | 6.08 USD |
| 12/14/2025 | 6.01 USD |
| 12/12/2025 | 6.03 USD |
| 12/11/2025 | 6.03 USD |
| 12/10/2025 | 6.00 USD |
| 12/9/2025 | 6.02 USD |
| 12/8/2025 | 5.99 USD |
| 12/7/2025 | 5.89 USD |
| 12/5/2025 | 6.02 USD |
| 12/4/2025 | 6.02 USD |
| 12/3/2025 | 5.94 USD |
| 12/2/2025 | 5.79 USD |
| 12/1/2025 | 5.77 USD |
| 11/30/2025 | 5.88 USD |
| 11/28/2025 | 5.79 USD |
| 11/27/2025 | 5.79 USD |
| 11/26/2025 | 5.68 USD |
| 11/25/2025 | 5.68 USD |
| 11/24/2025 | 5.69 USD |
| 11/23/2025 | 5.62 USD |
| 11/21/2025 | 5.75 USD |
| 11/20/2025 | 5.75 USD |
| 11/19/2025 | 5.80 USD |
| 11/18/2025 | 6.01 USD |
| 11/17/2025 | 6.04 USD |
| 11/16/2025 | 6.10 USD |
| 11/14/2025 | 6.15 USD |
| 11/13/2025 | 6.15 USD |
| 11/12/2025 | 6.17 USD |
| 11/11/2025 | 6.14 USD |
| 11/10/2025 | 6.35 USD |
| 11/9/2025 | 6.30 USD |
| 11/7/2025 | 6.35 USD |
| 11/6/2025 | 6.35 USD |
| 11/5/2025 | 6.56 USD |
| 11/4/2025 | 7.00 USD |
| 11/3/2025 | 7.07 USD |
| 11/2/2025 | 7.08 USD |
| 10/31/2025 | 7.17 USD |
| 10/30/2025 | 7.17 USD |
| 10/29/2025 | 7.30 USD |
| 10/28/2025 | 7.47 USD |
| 10/27/2025 | 7.25 USD |
| 10/26/2025 | 7.25 USD |
| 10/23/2025 | 7.36 USD |
| 10/22/2025 | 7.68 USD |
| 10/21/2025 | 7.45 USD |
| 10/20/2025 | 7.61 USD |
| 10/19/2025 | 7.55 USD |
| 10/16/2025 | 7.55 USD |
| 10/15/2025 | 7.67 USD |
| 10/14/2025 | 7.35 USD |
| 10/13/2025 | 7.50 USD |
| 10/12/2025 | 7.50 USD |
| 10/9/2025 | 7.44 USD |
| 10/8/2025 | 7.55 USD |
| 10/7/2025 | 7.59 USD |
| 10/6/2025 | 7.51 USD |
| 10/5/2025 | 7.56 USD |
| 10/2/2025 | 7.76 USD |
| 10/1/2025 | 8.09 USD |
| 9/30/2025 | 7.69 USD |
| 9/29/2025 | 7.86 USD |
| 9/28/2025 | 7.62 USD |
| 9/25/2025 | 7.76 USD |
| 9/24/2025 | 7.74 USD |
| 9/23/2025 | 7.58 USD |
| 9/22/2025 | 7.86 USD |
| 9/21/2025 | 7.96 USD |
| 9/18/2025 | 7.95 USD |
| 9/17/2025 | 7.93 USD |
| 9/16/2025 | 7.99 USD |
| 9/15/2025 | 8.18 USD |
| 9/14/2025 | 7.95 USD |
| 9/11/2025 | 7.80 USD |
| 9/10/2025 | 8.20 USD |
| 9/9/2025 | 8.46 USD |
| 9/8/2025 | 8.50 USD |
| 9/7/2025 | 8.45 USD |
| 9/4/2025 | 8.51 USD |
| 9/3/2025 | 8.52 USD |
| 9/2/2025 | 8.69 USD |
| 9/1/2025 | 8.53 USD |
| 8/28/2025 | 8.41 USD |
| 8/27/2025 | 8.03 USD |
| 8/26/2025 | 8.09 USD |
| 8/25/2025 | 8.19 USD |
| 8/24/2025 | 8.04 USD |
| 8/21/2025 | 8.37 USD |
| 8/20/2025 | 8.30 USD |
| 8/19/2025 | 7.96 USD |
| 8/18/2025 | 7.83 USD |
| 8/17/2025 | 7.81 USD |
| 8/14/2025 | 7.87 USD |
| 8/13/2025 | 7.86 USD |
| 8/12/2025 | 8.06 USD |
| 8/11/2025 | 8.05 USD |
| 8/10/2025 | 7.85 USD |
United-Guardian Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
United-Guardian Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| DIVIDENDDIV.USD |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.00 | 14.00 | 13.00 | 15.00 | 13.00 | 14.00 | 10.00 | 12.00 | 13.00 | 13.00 | 10.00 | 13.00 | 12.00 | 10.00 | 12.00 | 10.00 |
| – | 7.69 | -7.14 | 15.38 | -13.33 | 7.69 | -28.57 | 20.00 | 8.33 | – | -23.08 | 30.00 | -7.69 | -16.67 | 20.00 | -16.67 |
| 61.54 | 57.14 | 61.54 | 60.00 | 61.54 | 57.14 | 50.00 | 58.33 | 61.54 | 53.85 | 60.00 | 61.54 | 50.00 | 50.00 | 50.00 | 50.00 |
| 8.00 | 8.00 | 8.00 | 9.00 | 8.00 | 8.00 | 5.00 | 7.00 | 8.00 | 7.00 | 6.00 | 8.00 | 6.00 | 5.00 | 6.00 | 5.00 |
| 5.00 | 6.00 | 6.00 | 7.00 | 5.00 | 6.00 | 3.00 | 5.00 | 5.00 | 5.00 | 3.00 | 5.00 | 4.00 | 2.00 | 3.00 | 2.00 |
| 38.46 | 42.86 | 46.15 | 46.67 | 38.46 | 42.86 | 30.00 | 41.67 | 38.46 | 38.46 | 30.00 | 38.46 | 33.33 | 20.00 | 25.00 | 20.00 |
| 3.00 | 4.00 | 4.00 | 5.00 | 4.00 | 4.00 | 2.00 | 3.00 | 4.00 | 4.00 | 3.00 | 4.00 | 2.00 | 2.00 | 3.00 | 2.00 |
| – | 33.33 | – | 25.00 | -20.00 | – | -50.00 | 50.00 | 33.33 | – | -25.00 | 33.33 | -50.00 | – | 50.00 | -33.33 |
| 0.63 | 0.80 | 0.86 | 0.97 | 0.80 | 1.00 | 0.75 | 1.34 | 1.05 | 1.10 | 0.78 | 1.13 | 0.68 | 0.20 | 0.60 | 0.60 |
| 5.00 | 26.98 | 7.50 | 12.79 | -17.53 | 25.00 | -25.00 | 78.67 | -21.64 | 4.76 | -29.09 | 44.87 | -39.82 | -70.59 | 200.00 | – |
| 4.60 | 4.60 | 4.60 | 4.60 | 4.60 | 4.59 | 4.59 | 4.59 | 4.59 | 4.59 | 4.59 | 4.59 | 4.59 | 4.59 | 4.59 | 4.59 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales United-Guardian generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue United-Guardian retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare United-Guardian's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares United-Guardian has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against United-Guardian's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
United-Guardian stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
United-Guardian Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
United-Guardian business model & stock analysis
United-Guardian SWOT Analysis
Strengths
United-Guardian Inc has a diverse and extensive product portfolio, offering a wide range of specialty chemicals and pharmaceuticals. This allows them to cater to various industries and market segments, reducing dependency on specific products or markets.
With a long history of serving the industry since 1942, United-Guardian Inc has built a solid brand reputation for delivering high-quality and reliable products. This reputation helps in attracting and retaining customers, ensuring long-term business relationships.
United-Guardian Inc has demonstrated strong financial performance over the years, with consistent revenue growth and profitability. This enables them to invest in research and development, expand their product offerings, and pursue strategic opportunities for growth.
Weaknesses
United-Guardian Inc has a relatively limited international presence, primarily operating within the United States. This may limit their growth potential in global markets and expose them to regional economic fluctuations or regulatory challenges.
United-Guardian Inc relies heavily on a few key customers for a significant portion of their revenue. This concentration of customer base poses risks, as the loss of any major customer could have a substantial negative impact on their financial performance.
Opportunities
The increasing demand for specialty chemicals in various industries, such as pharmaceuticals, personal care, and pet care, presents an opportunity for United-Guardian Inc to expand its market reach and grow its customer base. By leveraging their expertise and product portfolio, they can tap into new market segments and increase revenue.
United-Guardian Inc can explore expansion opportunities in emerging markets, where there is a rising demand for specialty chemicals and pharmaceuticals. Establishing a presence in these markets can provide access to new customers and revenue streams, while diversifying their geographic footprint.
Threats
United-Guardian Inc operates in a highly competitive industry, facing competition from both domestic and international players. This poses a threat to their market share, pricing power, and profitability, requiring constant innovation and differentiation to stay ahead.
The regulatory environment for specialty chemicals and pharmaceuticals is subject to constant changes and updates. United-Guardian Inc needs to remain vigilant and adapt to these regulations to ensure compliance and avoid any potential legal or reputational risks.
United-Guardian Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
United-Guardian Segments
United-Guardian Revenue by Segment
3 Years
5 Years
Max
Details
United-Guardian Revenue by Region
3 Years
5 Years
10 Years
Max
Details
United-Guardian Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
United-Guardian historical P/E ratio, EBIT multiple, and P/S ratio
United-Guardian annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
United-Guardian shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
United-Guardian Dividend History
31 years of dividend payments
United-Guardian dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
United-Guardian dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
United-Guardian shareholder structure
| % | Name |
|---|---|
4.29881% | |
4.09122% | |
3.27353% | |
1.95386% | |
1.67440% | |
1.17452% |
United-Guardian Beneficial Ownership Filings (SEC 13D/G)
United-Guardian Executives and Management Board
9 members · avg. age 67 · 33 % women
Ms. Donna Vigilante (45)
President, Director · since 2017
297,865.00 USD
Management
Mr. Peter Hiltunen (66)
Senior Vice President, Production and Procurement
Ms. Andrea Young (56)
Principal Financial Officer, Controller, Treasurer and Secretary · since 2020
Board of Directors
Mr. Lawrence Maietta (67)
Independent Director · since 1991
Mr. Kenneth Globus (73)
Chairman of the Board · since 1988
Mr. Andrew Boccone (79)
Independent Director
Mr. Arthur Dresner (83)
Independent Director
Ms. Catherine Kolinski (67)
Independent Director
Mr. S. Ari Papoulias (71)
Independent Director
United-Guardian Supply Chain
United-Guardian Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | -0.21 | 0.31 | 0.45 |
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | -0.41 | — | — | ||
| 2 | -0.67 | -0.47 | 0.16 |
Frequently asked questions about United-Guardian
United-Guardian Inc is a company that specializes in the development, manufacturing, and marketing of cosmetic ingredients, pharmaceuticals, and personal care products. Their business model revolves around providing high-quality and innovative solutions to their customers in various industries. With a focus on research and development, United-Guardian Inc aims to create products that address specific needs and deliver exceptional results. Through their extensive portfolio and commitment to customer satisfaction, United-Guardian Inc has established itself as a trusted provider in the market, consistently delivering value to its clients.
United-Guardian Inc is primarily active in the pharmaceutical and personal care industries.
The main competitors of United-Guardian Inc in the market include companies such as Johnson & Johnson, Procter & Gamble, and Kimberly-Clark. These industry giants operate in the consumer goods sector and offer similar products and technologies. United-Guardian Inc faces competition in areas such as personal care products, pharmaceuticals, and medical devices. Despite a competitive market, United-Guardian Inc has managed to establish a strong foothold with its innovative product portfolio and a dedicated customer base.
United-Guardian Inc, founded in 1942, is a leading specialty chemical manufacturer based in the United States. The company specializes in the research, development, and production of pharmaceuticals, personal care ingredients, cosmetic ingredients, and health care products. With extensive experience and a strong reputation, United-Guardian has established itself as a trusted supplier to various industries worldwide. The company's commitment to innovation, quality, and customer satisfaction has enabled it to grow steadily over the years. Today, United-Guardian continues to provide innovative solutions and reliable products that meet the highest industry standards, making it a reputable and sought-after company in the market.
United-Guardian Inc. has achieved several significant milestones since its inception. The company has established a strong reputation in the pharmaceutical and personal care industries. Notably, United-Guardian Inc. developed and patented its highly effective pharmaceutical product called Renacidin®, used for treating and preventing catheter encrustation and blockage. The company has also made advancements in the field of personal care, creating innovative ingredients like Lubrajel®, a line of moisturizers used in cosmetics and skincare products. Additionally, United-Guardian Inc. has expanded its global reach by forming strategic partnerships and expanding distribution channels. These achievements showcase United-Guardian Inc.'s dedication to innovation and success in its respective industries.
United-Guardian Inc is primarily present in the United States.
United-Guardian Inc represents strong core values and a clear corporate philosophy. The company is committed to providing superior products and services to its customers, focusing on customer satisfaction and long-term relationships. United-Guardian Inc prioritizes quality, innovation, and integrity in all aspects of its operations. With a history of over 75 years, the company has built a reputation for excellence and reliability. United-Guardian Inc strives to be a leader in its industry, continuously improving and adapting to meet evolving market demands. Through its dedication to its values and philosophy, United-Guardian Inc aims to deliver consistent value to its stakeholders and maintain its position as a trusted and respected stock in the market.
Converted at the current exchange rate, the United-Guardian share trades at 6.27 EUR (7.24 USD).
The United-Guardian share (UG) is listed on 1 stock exchanges, including: NASDAQ (UG).
United-Guardian Inc is a company that has been engaged in the development and production of pharmaceutical, cosmetic, and industrial products since 1942. The company is headquartered in New York and distributes its products worldwide. The business model of United-Guardian is focused on the production and sale of pharmaceutical and cosmetic ingredients that are used in many industries. The products are divided into four main areas: Pharmaceuticals, Cosmetics, Personal Care, and Industrial Applications. In the Pharmaceuticals segment, United-Guardian produces and distributes ingredients that are used in medicine, veterinary medicine, and the production of dietary supplements. These include potassium dihydrogen phosphate, sodium cyclamate, aluminum hydroxide, magnesium hydroxide, and sodium pyrosulfite. Production takes place in its own facilities and is controlled according to the highest quality standards. In the cosmetics industry, United-Guardian offers a variety of ingredients that are used in skincare, hair care, deodorants, and sunscreens. These include phenylbutyl acetate, dimethylpyrazine, and piroctone olamine. These ingredients are developed in close collaboration with customers and tailored to their needs. The Personal Care segment includes products such as shampoos, conditioners, and hair dyes that are used by customers worldwide. United-Guardian manufactures products based on natural ingredients and of high quality. This includes products like the Sanitized process, which reduces bacteria and fungi and improves the shelf life of cosmetics. The industrial segment of United-Guardian covers a wide range of applications. These include products such as polyvinyl acetate, ethyl cellulose, and methacrylic acid-methacrylate copolymer. These ingredients are used in applications such as adhesives, coatings, and lubricants, offering high quality and performance. Overall, the business model of United-Guardian is characterized by close collaboration with customers and high manufacturing competence. The production of high-quality ingredients and products for various industries is an important part of United-Guardian's business model. The company places a special focus on quality assurance and continuous improvement, as evidenced by its certification to ISO 9001 and ISO 14001. In summary, United-Guardian's business model is focused on the production of pharmaceutical, cosmetic, and industrial products. The company works closely with customers to develop products that meet their individual requirements. A special emphasis is placed on quality assurance and continuous improvement.
The revenue cannot currently be calculated for United-Guardian.
The profit cannot currently be calculated for United-Guardian.
The P/E ratio cannot be calculated for United-Guardian at the moment.
The P/S cannot be calculated for United-Guardian currently.
The Eulerpool Quality Score for United-Guardian is 2/10.
The ISIN of United-Guardian is US9105711082. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of United-Guardian is 867399. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of United-Guardian is UG. The ticker symbol is used to trade United-Guardian shares on the stock exchange.
Over the past 12 months, United-Guardian paid a dividend of 0.60 USD . This corresponds to a dividend yield of about 8.29 %. For the coming 12 months, United-Guardian is expected to pay a dividend of 0.60 USD.
The current dividend yield of United-Guardian is 8.29 %.
United-Guardian pays a dividend, distributed in the months of , , , .
United-Guardian paid dividends every year for the past 30 years.
For the upcoming 12 months, dividends amounting to 0.60 USD are expected. This corresponds to a dividend yield of 8.29 %.
United-Guardian is assigned to the 'Non-cyclical consumption' sector.
To receive the latest dividend of United-Guardian from amounting to 0.3 USD, you needed to have the stock in your portfolio before the ex-date on .
The last dividend was paid out on .
In the year 2025, United-Guardian distributed 0.6 USD as dividends.
The dividends of United-Guardian are distributed in USD.
United-Guardian stock
United-Guardian Peer Group
United-Guardian Ticker
United-Guardian FIGI
All fundamentals and in-depth analysis of United-Guardian
Our stock analysis for United-Guardian stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of United-Guardian. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.